Carolina Contreras Cuevas/LinkedIn
Oct 24, 2025, 10:03
Debunking Myths with Carolina Contreras Cuevas: The AQUARIUS Trial That Had to Be Stopped
Carolina Contreras Cuevas, Hematologist, Medical Center and Interconsultant Physician at RedSalud CCHC, shared a post on LinkedIn:
“Debunking Myths.
The AQUARIUS study on the use of ASA + anticoagulant (VKA or DOAC) in patients with chronic coronary syndrome, already with a stent implanted for >6 months, and on anticoagulation for another reason.
Spoiler: The study had to be stopped early at 2.2 years.”
Read full paper here.
Stay informed with Hemostasis Today.
-
Sep 10, 2026, 05:12Douglas S. Campbell: Great to See a Strong Japanese Presence in 2026 Lasker Awards
-
Sep 10, 2026, 05:11Jan Hartmann: New Transformative Treatment for Hemophilia A
-
Sep 10, 2026, 05:09Shelby Bradford: Award-Winning Science Incoming
-
Sep 9, 2026, 17:57CRISPR/Cas Gene Editing in β-Thalassemia: From Molecular Correction to Clinical Reality
-
Sep 9, 2026, 17:38Cardiovascular Health in Bleeding Disorders – EHC
-
Sep 9, 2026, 17:33Manasvi Shah: Co-Inheritance of Alpha Globin Gene Multiplication With Beta Globin Gene Abnormalities
-
Sep 9, 2026, 17:29Christina Crossette-Thambiah: One of the Largest Studies to Date in Antiphospholipid Syndrome
-
Sep 9, 2026, 17:25Alan Nurden: A miR-146a Variant Reveals a New Pathway Linking Platelet Metabolism and Thrombosis
-
Sep 9, 2026, 17:17When Is Thrombophilia Testing Appropriate and How Can the Evidence Guide Clinical Care? – ISTH